![](https://thepharmadata.com/wp-content/uploads/2024/07/Immunization_11zon-768x512.jpg)
June 2024 Message from WHO Immunization Director
WHO and UNICEF have unveiled new national immunization coverage estimates (WUENIC), offering the most comprehensive view of global vaccination trends for 13 diseases. The findings present both progress and pressing…
![](https://thepharmadata.com/wp-content/uploads/2024/07/WHO-at-the-25th-International-AIDS-Conference_11zon-768x512.webp)
WHO at the 25th International AIDS Conference
The WHO is actively participating in the 25th International AIDS Conference (AIDS 2024) in Munich, Germany, and online from July 20 to 26. During a series of pre-conference sessions and…
![](https://thepharmadata.com/wp-content/uploads/2024/07/WHO-Updates-HIV-Testing-Boost-for-Self-Testing_-Integration_-and-Prevention-768x512.webp)
WHO Updates HIV Testing: Boost for Self-Testing, Integration, and Prevention
Each year, over a million people acquire preventable HIV infections, and many others with HIV remain undiagnosed and untreated. Quality testing services are crucial for reaching, treating, and preventing HIV,…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Opdivo®-Approved-in-South-Korea-for-First-Line-Treatment-of-Unresectable-or-Metastatic-Urothelial-Carcinoma-1-768x512.webp)
Opdivo® Approved in South Korea for First-Line Treatment of Unresectable or Metastatic Urothelial Carcinoma
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino) announced today that its Korean subsidiary, Ono Pharma Korea Co., Ltd. (OPKR), received additional approval from South Korea’s Ministry of…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Neurocrine-Biosciences-Launches-INGREZZA®-SPRINKLE-for-Easier-Swallowing-768x512.webp)
Neurocrine Biosciences Launches INGREZZA® SPRINKLE for Easier Swallowing
Neurocrine Biosciences has introduced a new sprinkle formulation of INGREZZA® (valbenazine) capsules, the leading VMAT2 inhibitor for treating adults with tardive dyskinesia and chorea associated with Huntington’s disease. This new…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Labcorp-Achieves-Highest-Rating-on-the-2024-Disability-Equality-Index®-1-768x512.webp)
Labcorp Achieves Highest Rating on the 2024 Disability Equality Index®
Labcorp, a leading global life sciences company, has been recognized as a top employer for disability inclusion by achieving a perfect score of 100 on the 2024 Disability Equality Index®.…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Biologics-768x512.webp)
WuXi Biologics Secures Place in FTSE4Good Index Series for Fourth Consecutive Year
A prominent global Contract Research, Development, and Manufacturing Organization (CRDMO), has once again been named a constituent of the FTSE4Good Index Series. This recognition, marking the fourth year in a…
![](https://thepharmadata.com/wp-content/uploads/2024/07/BeiGene-Names-Aaron-Rosenberg-as-New-Chief-Financial-Officer-768x512.webp)
BeiGene Names Aaron Rosenberg as New Chief Financial Officer
BeiGene, a global oncology company, has announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22. Rosenberg will succeed Julia Wang, who is leaving to pursue other…
![](https://thepharmadata.com/wp-content/uploads/2024/07/argenx-and-Zai-Lab-Announce-Efgartigimod-Alfa-Approval-for-Myasthenia-Gravis-in-China-768x512.webp)
argenx and Zai Lab Announce Efgartigimod Alfa Approval for Myasthenia Gravis in China
Today, argenx and Zai Lab announced that China’s National Medical Products Administration (NMPA) approved the Biologics License Application (BLA) for efgartigimod alfa injection (subcutaneous) on July 16, 2024. This 1,000mg…
![](https://thepharmadata.com/wp-content/uploads/2024/07/WuXi-AppTec-Repeats-as-FTSE4Good-Index-Series-Member-768x512.webp)
WuXi AppTec Repeats as FTSE4Good Index Series Member
WuXi AppTec, a leading global provider of R&D and manufacturing services for the pharmaceutical and life sciences industries, has been named to the FTSE4Good Index Series for the second consecutive…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Semiconductor-Solutions-2-768x512.webp)
Merck to Acquire Unity-SC, Enhancing AI-Enabled Semiconductor Solutions
Merck, a leading science and technology company, plans to acquire Unity-SC, a provider of metrology and inspection instruments for the semiconductor industry. The deal includes an initial payment of €155…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Merck-Launches-First-GMP-Compliant-Cell-Culture-Media-Production-Line-in-China-768x512.webp)
Merck Launches First GMP-Compliant Cell Culture Media Production Line in China
Merck, a leader in science and technology, has announced the launch of its first GMP (Good Manufacturing Practices) compliant cell culture media (CCM) manufacturing line in China. The new facility,…